Author:
Taylor Kirstin M.,Irving Peter M.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Reference111 articles.
1. Colombel, J. F. et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N. Engl. J. Med. 362, 1383–1395 (2010).
2. Pannacionne, R. et al. Infliximab, azathioprine, or infliximab + azathioprine for treatment of moderate to severe ulcerative colitis: The UC Success Trial. Gastroenterology 140 (Suppl. 1), S134 (2011).
3. Gisbert, J. P. & Panes, J. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review. Am. J. Gastroenterol. 104, 760–767 (2009).
4. Louis, E. et al. Infliximab discontinuation in Crohn's disease patients in stable remission on combined therapy with immunosuppressors: interim analysis of a prospective cohort study. Gut 57, A66 (2008).
5. Infliximab (review) and adalimumab for the treatment of Crohn's disease. NICE technology appraisal guidance 187. National Institute for Clinical Excellence [online] , (2010).
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献